Efficacy and safety evaluation of neoadjuvant immunotherapy plus chemotherapy for resectable non–small cell lung cancer in real world

OBJECTIVES: The combination of immunotherapy and chemotherapy has shown great efficacy in stage IV non–small cell lung cancer (NSCLC) and is now widely used in clinical treatment strategy. This study retrospectively analyzed the efficacy and safety of neoadjuvant immunotherapy plus chemotherapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Min, Hang, Qingqing, Jiang, Haitao, Cai, Lei, Hu, Jinlin, Ying, Hangjie, Gu, Qing, Yu, Xiaofu, Liu, Jinshi, Lai, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877512/
https://www.ncbi.nlm.nih.gov/pubmed/36713546
http://dx.doi.org/10.3389/fonc.2022.1055610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877512/
https://www.ncbi.nlm.nih.gov/pubmed/36713546
http://dx.doi.org/10.3389/fonc.2022.1055610

Ejemplares similares